Watch Ticker

Scholar Rock Holding Corporation Common Stock

Go to Scholar Rock Holding Corporation Common Stock Website

$36.98

0.00 (0.00%)
Live
Previous Close

$36.98

Day Range

$0 - $0

Previous Day Range

$35.82 - $37.135

Market Cap

$3.5 billion USD

Day Vol.

0

Previous Day Vol.

2.0 million

Currency

USD

Primary Exchange

Nasdaq

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipel...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Biotech stock Scholar Rock (SRRK) jumped nearly 3% on Wednesday after a positive analyst note from Piper Sandler's Allison Bratzel. Bratzel believes the company's lead drug candidate, apitegromab, is undervalued and could see significant upside if approved for treating spinal muscular atrophy (SMA).

Related tickers: SRRK.

Read Full Article

Scholar Rock, a clinical-stage drugmaker, has developed a treatment candidate called apitegromab that prevents muscle loss. Results from a late-stage clinical trial suggest apitegromab can become a blockbuster-companion treatment for patients with a rare muscle-wasting disorder, leading to a 364% surge in the company's stock price.

Related tickers: SRRK, BIIB, RHHBY, LLY, NVO.

Read Full Article
Trending Tickers

Please sign in to view